Neoambrosin
Neoambrosin is a sesquiterpene lactone. Neoambrosin acts as a partial agonist of PPARγ and TRPA1 receptors, with no carbonic anhydrase inhibitory activity. Neoambrosin can be used in research on hypoglycemia, analgesia, anti-inflammation and anticancer effects.
For research use only. We do not sell to patients.
- CAS No.: 18446-70-3
- Formula: C15H18O3
- Molecular Weight:246.31
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
IC50 & Target
[1]|
TRPA1 |
PPARγ |
In Vitro
Neoambrosin (0.1-50 μM; 24 h) reduces viability of COS-7 cells at 30 μM and 50 μM after 24 h of treatment, with no significant effect at lower concentrations[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:COS-7 monkey kidney fibroblast-like cells
-
Concentration:0.1 μM; 1 μM; 3 μM; 10 μM; 30 μM; 50 μM
-
Incubation Time:24 h
-
Result:Reduced cell viability by approximately 50% relative to vehicle at 30 μM.
Reduced cell viability by approximately 70% relative to vehicle at 50 μM.
Did not significantly affect cell viability relative to vehicle at 0.1, 1, 3, and 10 μM.
Chemical Information
-
CAS No. 18446-70-3
-
Molecular Weight 246.31
-
Formula C15H18O3
-
SMILES
C[C@]12[C@]3([C@](C(=C)C(=O)O3)(CC[C@H](C)C1=CCC2=O)[H])[H]
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Neoambrosin Related Classifications
HY-127003 Related Classifications
Powered by Bioz